Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Change in Cash (2021 - 2025)

Historic Change in Cash for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to -$841128.0.

  • HeartSciences' Change in Cash fell 19240.56% to -$841128.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$2.1 million, marking a year-over-year decrease of 15316.37%. This contributed to the annual value of -$4.7 million for FY2025, which is 21356.03% down from last year.
  • Per HeartSciences' latest filing, its Change in Cash stood at -$841128.0 for Q4 2025, which was down 19240.56% from $1.7 million recorded in Q3 2025.
  • HeartSciences' 5-year Change in Cash high stood at $7.0 million for Q1 2024, and its period low was -$1.5 million during Q2 2025.
  • Its 5-year average for Change in Cash is $68201.2, with a median of -$596500.5 in 2021.
  • Per our database at Business Quant, HeartSciences' Change in Cash plummeted by 42836.69% in 2022 and then surged by 70928.1% in 2024.
  • Over the past 5 years, HeartSciences' Change in Cash (Quarter) stood at $364389.0 in 2021, then plummeted by 428.37% to -$1.2 million in 2022, then soared by 60.26% to -$475510.0 in 2023, then surged by 39.51% to -$287658.0 in 2024, then tumbled by 192.41% to -$841128.0 in 2025.
  • Its Change in Cash was -$841128.0 in Q4 2025, compared to $1.7 million in Q3 2025 and -$1.5 million in Q2 2025.